A Placebo-controlled, Randomized Clinical Trial to Assess the Safety, Feasibility, and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension
Abroad (travel likely)RecruitingPHASE1
Conditions
Pulmonary Arterial Hypertension
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Minnesota, Minneapolis, Minnesota, United States
Contact: Study coordinator (Gretchen Peichel)
Study leads
Thenappan Thenappan, MD
Principal Investigator
University of Minnesota
Levi Teigen, MD, PhD
Principal Investigator
University of Minnesota
Alexander Khoruts, MD
Principal Investigator
University of Minnesota
Christopher Staley, PhD
Principal Investigator
University of Minnesota
Kurt Prins, MD,PhD
Principal Investigator
University of Minnesota
Edward Weirs, MD
Principal Investigator
University of Minnesota